TELA Bio Inc (NASDAQ:TELA) reported mixed results for the third quarter on Thursday.The company posted quarterly losses of 19 cents per share which beat the analyst consensus estimate of losses of 20 cents per share. The company reported quarterly sales of $20.700 million which missed the analyst consensus estimate of$21.788 million.“We demonstrated continued growth and meaningful progress this quarter, resulting from a strengthened leadership team and strategic changes to enhance our commercial organizati ...